BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26976307)

  • 21. Interactive effect of 5-HTTLPR and BDNF polymorphisms on amygdala intrinsic functional connectivity and anxiety.
    Loewenstern J; You X; Merchant J; Gordon EM; Stollstorff M; Devaney J; Vaidya CJ
    Psychiatry Res Neuroimaging; 2019 Mar; 285():1-8. PubMed ID: 30711709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic epistasis between the brain-derived neurotrophic factor Val66Met polymorphism and the 5-HTT promoter polymorphism moderates the susceptibility to depressive disorders after childhood abuse.
    Grabe HJ; Schwahn C; Mahler J; Appel K; Schulz A; Spitzer C; Fenske K; Barnow S; Freyberger HJ; Teumer A; Petersmann A; Biffar R; Rosskopf D; John U; Völzke H
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):264-70. PubMed ID: 21996278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of the brain-derived neurotrophic factor Val66Met polymorphism with hippocampus volumes in drug-free depressed patients.
    Gonul AS; Kitis O; Eker MC; Eker OD; Ozan E; Coburn K
    World J Biol Psychiatry; 2011 Mar; 12(2):110-8. PubMed ID: 20726825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cumulative effect of genetic polymorphisms on depression and brain structural integrity.
    Kostic M; Canu E; Agosta F; Munjiza A; Novakovic I; Dobricic V; Maria Ferraro P; Miler Jerkovic V; Pekmezovic T; Lecic Tosevski D; Filippi M
    Hum Brain Mapp; 2016 Jun; 37(6):2173-84. PubMed ID: 26956059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population.
    Aguilera M; Arias B; Wichers M; Barrantes-Vidal N; Moya J; Villa H; van Os J; Ibáñez MI; Ruipérez MA; Ortet G; Fañanás L
    Psychol Med; 2009 Sep; 39(9):1425-32. PubMed ID: 19215635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BDNF val66met association with serotonin transporter binding in healthy humans.
    Fisher PM; Ozenne B; Svarer C; Adamsen D; Lehel S; Baaré WF; Jensen PS; Knudsen GM
    Transl Psychiatry; 2017 Feb; 7(2):e1029. PubMed ID: 28195567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactive effects of genetic polymorphisms and childhood adversity on brain morphologic changes in depression.
    Kim YK; Ham BJ; Han KM
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Apr; 91():4-13. PubMed ID: 29535036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the BDNF Val66Met polymorphism on neural responses to facial emotion.
    Mukherjee P; Whalley HC; McKirdy JW; McIntosh AM; Johnstone EC; Lawrie SM; Hall J
    Psychiatry Res; 2011 Mar; 191(3):182-8. PubMed ID: 21310593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulatory effects of brain-derived neurotrophic factor Val66Met polymorphism on prefrontal regions in major depressive disorder.
    Legge RM; Sendi S; Cole JH; Cohen-Woods S; Costafreda SG; Simmons A; Farmer AE; Aitchison KJ; McGuffin P; Fu CH
    Br J Psychiatry; 2015 May; 206(5):379-84. PubMed ID: 25745134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression.
    Bocchio-Chiavetto L; Miniussi C; Zanardini R; Gazzoli A; Bignotti S; Specchia C; Gennarelli M
    Neurosci Lett; 2008 May; 437(2):130-4. PubMed ID: 18450378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of BDNF Val66Met and serotonin transporter 5-HTTLPR polymorphisms on psychopathological characteristics in a sample of university students.
    Kourmouli N; Samakouri M; Mamatsiou A; Trypsianis G; Livaditis M; Veletza S
    Psychiatr Genet; 2013 Oct; 23(5):188-97. PubMed ID: 23884433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients.
    Zou YF; Wang Y; Liu P; Feng XL; Wang BY; Zang TH; Yu X; Wei J; Liu ZC; Liu Y; Tao M; Li HC; Li KQ; Hu J; Li M; Zhang KR; Ye DQ; Xu XP
    Neuropsychobiology; 2010; 61(2):71-8. PubMed ID: 20016225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder.
    Matsuo K; Walss-Bass C; Nery FG; Nicoletti MA; Hatch JP; Frey BN; Monkul ES; Zunta-Soares GB; Bowden CL; Escamilla MA; Soares JC
    Neuropsychopharmacology; 2009 Jul; 34(8):1904-13. PubMed ID: 19295510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele.
    Cao B; Bauer IE; Sharma AN; Mwangi B; Frazier T; Lavagnino L; Zunta-Soares GB; Walss-Bass C; Glahn DC; Kapczinski F; Nielsen DA; Soares JC
    J Affect Disord; 2016 Jul; 198():198-205. PubMed ID: 27018938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotypes do not confer risk for delinquency but rather alter susceptibility to positive and negative environmental factors: gene-environmentinteractions of BDNF Val66Met, 5-HTTLPR, and MAOA-uVNTR [corrected].
    Nilsson KW; Comasco E; Hodgins S; Oreland L; Åslund C
    Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroimaging genetics: new perspectives in research on major depression?
    Frodl T; Möller HJ; Meisenzahl E
    Acta Psychiatr Scand; 2008 Nov; 118(5):363-72. PubMed ID: 18644006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of polymorphisms of serotonin transporter promoter (5-HTTLPR) and brain derived neurotrophic factor gene (G196A rs6265) on the risk of major depressive disorder in the Chinese Han population.
    Sun N; Yang CX; Liu ZF; Li XR; Xu Y; Zhang KR
    Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1852-9. PubMed ID: 27212180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-way interaction effect of 5-HTTLPR, BDNF Val66Met, and childhood adversity on depression: a replication study.
    Comasco E; Åslund C; Oreland L; Nilsson KW
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1300-6. PubMed ID: 23481907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emotional fronto-cingulate cortex activation and brain derived neurotrophic factor polymorphism in premenstrual dysphoric disorder.
    Comasco E; Hahn A; Ganger S; Gingnell M; Bannbers E; Oreland L; Wikström J; Epperson CN; Lanzenberger R; Sundström-Poromaa I
    Hum Brain Mapp; 2014 Sep; 35(9):4450-8. PubMed ID: 24615932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of BDNF val66met polymorphism on age-related amygdala volume changes in healthy subjects.
    Sublette ME; Baca-Garcia E; Parsey RV; Oquendo MA; Rodrigues SM; Galfalvy H; Huang YY; Arango V; Mann JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1652-5. PubMed ID: 18621091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.